Latest News
Linden Capital Partners and Audax Private Equity Partner to Invest in StatLab Medical
Wednesday 13 January 2021

US private equity firms Audax Private Equity and Linden Capital Partners have partnered to acquire Texas-based StatLab Medical Products, a manufacturer and distributor of consumables, reagents, and equipment used by anatomic pathology, molecular diagnostics, and other laboratories, the company said.

Terms of the transaction were not disclosed.

Linden's investment in StatLab builds upon our prior experience in the diagnostics sector, and we look forward to leveraging that experience to support the company's next phase of growth.

Ropes and Gray LLP and Kirkland and Ellis LLP served as legal advisors to Audax and Linden, and Cain Brothers, a division of KeyBanc Capital Markets, served as exclusive financial advisor. Robert W. Baird and Co. served as financial advisor to StatLab. Golub Capital provided debt financing for the transaction.

StatLab Medical Products is a developer and manufacturer of histology, cytology and immunohistochemistry diagnostic products. The company partners with anatomic pathology, molecular diagnostics, and other laboratories to provide over 5,000 diagnostic products and equipment.

Audax Private Equity is an alternative investment manager that has invested over USD 6bn in more than 135 platforms and over 900 add-on companies, and is currently investing out of its USD 3.5bn, sixth private equity fund.

Linden Capital Partners is a Chicago-based private equity firm focussed exclusively on the healthcare industry.
Date Published: 13/01/2021